Quick Answer
Bionano Genomics, Inc. reported Net Income of -$26.39 million for fiscal year 2025.
Bionano Genomics, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$26.39M | +76.4% |
| 2024 | -$112.02M | +51.8% |
| 2023 | -$232.49M | -75.3% |
| 2022 | -$132.60M | -83.1% |
| 2021 | -$72.44M | -76.2% |
| 2020 | -$41.11M | -37.9% |
| 2019 | -$29.82M | -61.2% |
| 2018 | -$18.50M | +20.8% |
| 2017 | -$23.37M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$8.50M | +80.8% | -24.0% |
| June 30, 2025 | -$6.86M | +57.7% | -121.1% |
| March 31, 2025 | -$3.10M | +90.1% | +93.0% |
| September 30, 2024 | -$44.25M | +60.7% | -172.7% |
| June 30, 2024 | -$16.22M | +58.3% | +48.4% |
| March 31, 2024 | -$31.42M | +15.4% | +72.1% |
| September 30, 2023 | -$112.57M | -253.9% | -189.3% |
| June 30, 2023 | -$38.91M | -21.0% | -4.8% |
- Bionano Genomics, Inc. showed an increase of +76.4% in Net Income compared to the prior fiscal year.
- Over the 2017–2025 period, Bionano Genomics, Inc.’s net income has declined by 13.0% (from -$23.37 million to -$26.39 million).
- The most recent figure is from Bionano Genomics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: